Treatment with a Ginkgo biloba extract, EGb 761, inhibits excitotoxicity in an animal model of spinocerebellar ataxia type 17

Spinocerebellar ataxia type 17 (SCA 17) is a polyglutamine disease caused by the expansion of CAG/CAA repeats in the TATA box-binding protein (TBP) gene. The Ginkgo biloba extract, EGb 761, contains flavonoids and terpenoids with a potential use for the treatment of neurodegenerative diseases such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ding-Siang, Lin, Hsuan-Yuan, Lee-Chen, Guey-Jen, Hsieh-Li, Hsiu-Mei, Wu, Chung-Hsin, Lin, Jung-Yaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762588/
https://www.ncbi.nlm.nih.gov/pubmed/26937174
http://dx.doi.org/10.2147/DDDT.S98156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762588/
https://www.ncbi.nlm.nih.gov/pubmed/26937174
http://dx.doi.org/10.2147/DDDT.S98156

Ejemplares similares